Johnson & Johnson to split into two publicly traded companies

USA – Johnson & Johnson, the world’s largest health-care conglomerate, has announced plans to separate its consumer products business from its pharmaceutical and medical device operations, resulting in the formation of two publicly traded companies. The consumer arm – comprised of million- and billion-dollar brands and offering products such as mouthwash, shampoo, and skincare – will form a new publicly traded company in the next 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies such as robotics and artificial intelligence, would keep the Johnson &…

Read More

Japan to bolster its fight against COVID-19 with launch of infectious disease databank

JAPAN – The Japanese government plans to launch an infectious diseases databank later this month, starting with a plan to collect data on 10,000 COVID-19 patients by next March, to help firms and universities develop effective treatments. Under the project, the government seeks to first collect blood and saliva samples as well as the treatment records of COVID-19 patients and make them available for firms and universities researching the disease, possibly from this fall. About 50 medical institutions are expected to join the project, and the databank will be managed…

Read More